Skip to Main Content

Author Details

Nicholas Ambulos
University of Maryland School of Medicine
1984
55
22
PMIDPaper TitleJournal TitlePublished Year
37633776Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.Schizophr Res2024
34080968Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid Leukemia.Anticancer Agents Med Chem2022
35763601Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program.Diabetes Care2022
35512605Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers.Mol Carcinog2022
36078112Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models.Cells2022
34840323Evaluating the Jaccard Similarity Index as a Persistence Measure of Multiple Anal Human Papillomavirus Among Nigerian Men Who Have Sex With Men.Sex Transm Dis2022
34624149Establishing a national strategy for shared research resources in biomedical sciences.FASEB J2021
33374332<i>MYC</i> DNA Methylation in Prostate Tumor Tissue Is Associated with Gleason Score.Genes (Basel)2020
30968179Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.Cancer Chemother Pharmacol2019
31653008Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo.Cancers (Basel)2019
30294391High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.J Hematop2018
28610586Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array.Virol J2017
28743660Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.J Pain Symptom Manage2017
27006646Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens.J Biomol Tech2016
26875057Educational innovations in clinical pharmacogenomics.Clin Pharmacol Ther2016
24726842VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats.Eur J Pharmacol2014
24616408Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.Am J Med Genet C Semin Med Genet2014
23588301The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.Clin Pharmacol Ther2013
21934603Antimetastatic activity isolated from Colocasia esculenta (taro).Anticancer Drugs2012
18549264PhosphoScan: a probability-based method for phosphorylation site prediction using MS2/MS3 pair information.J Proteome Res2008
17070539Robust gene expression with amplified RNA from biopsy-sized human heart tissue.J Mol Cell Cardiol2007
17440630Histidine-lysine peptides as carriers of nucleic acids.Drug News Perspect2007
15772938Highly branched HK peptides are effective carriers of siRNA.J Gene Med2005
14707368DNA delivery to cells in culture using peptides.Methods Mol Biol2004
12117952Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.Infect Immun2002
11824474Extracellular matrix-derived angiogenic factor(s) inhibit endothelial cell proliferation, enhance differentiation, and stimulate angiogenesis in vivo.Endothelium2001
19499054Strategies for the synthesis of labeled peptides.J Biomol Tech2000
9465392Characterization and expression analysis of a Xanthomonas oryzae pv. oryzae recA.FEMS Microbiol Lett1998
10694918A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.Hum Mutat1998
9298119Transfection enhancement in Bacillus subtilis displays features of a novel DNA repair pathway. I: DNA base and nucleolytic specificity.Mutat Res1997
9298120Transfection enhancement in Bacillus subtilis displays features of a novel DNA repair pathway. II: Host constitutive expression, repair DNA synthesis, and in vitro activity.Mutat Res1997
7883722Identification of a Bacillus subtilis spo0H allele that is necessary for suppression of the sporulation-defective phenotype of a spo0A mutation.J Bacteriol1995
7885839Lens-specific activity of the mouse alpha A-crystallin promoter in the absence of a TATA box: functional and protein binding analysis of the mouse alpha A-crystallin PE1 region.Nucleic Acids Res1995
7918439Evaluation of the internal equilibrium constant for 3-oxo-delta 5-steroid isomerase using the D38E and D38N mutants: the energetic basis for catalysis.Biochemistry1994
7689687Parallel induction strategies for cat-86: separating chloramphenicol induction from protein synthesis inhibition.Mol Microbiol1993
8406033Isolation and expression in Escherichia coli of a Xanthomonas oryzae recA-like gene.Gene1993
1720771Ribosome hopping and translational frameshifting are inadequate alternatives to translational attenuation in cat-86 regulation.J Bacteriol1991
1937000Constitutive expression of cat-86 associated with a change in the transcription start point.Gene1991
1900283UGA can be decoded as tryptophan at low efficiency in Bacillus subtilis.J Bacteriol1991
2121617CUG as a mutant start codon for cat-86 and xylE in Bacillus subtilis.Gene1990
2294082Four codons in the cat-86 leader define a chloramphenicol-sensitive ribosome stall sequence.J Bacteriol1990
2121710Complementarity of Bacillus subtilis 16S rRNA with sites of antibiotic-dependent ribosome stalling in cat and erm leaders.J Bacteriol1990
2507520Bacillus subtilis mutant allele sup-3 causes lysine insertion at ochre codons: use of sup-3 in studies of translational attenuation.J Bacteriol1989
3142854Induction of cat-86 by chloramphenicol and amino acid starvation in relaxed mutants of Bacillus subtilis.J Bacteriol1988
3133355Site in the cat-86 regulatory leader that permits amicetin to induce expression of the gene.J Bacteriol1988
3129723Chloramphenicol induction of cat-86 requires ribosome stalling at a specific site in the leader.Proc Natl Acad Sci U S A1988
2439407Method for blot-hybridization analysis of mRNA molecules from Bacillus subtilis.Gene1987
3114238Drug-free induction of a chloramphenicol acetyltransferase gene in Bacillus subtilis by stalling ribosomes in a regulatory leader.J Bacteriol1987
3029040The mRNA for an inducible chloramphenicol acetyltransferase gene is cleaved into discrete fragments in Bacillus subtilis.J Bacteriol1987
3462183Analysis of the regulatory sequences needed for induction of the chloramphenicol acetyltransferase gene cat-86 by chloramphenicol and amicetin.J Bacteriol1986
  • 1 - 50 of 55

Recommended Authors

University of Dundee
Career Start Year 2004
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 1998
Number of shared co-authors 0
Ottawa Institute of Systems Biology, Carleton University
Career Start Year 1997
Number of shared co-authors 0
Institute of Biochemistry, HUN-REN Biological Research Centre
Career Start Year 1991
Number of shared co-authors 0
University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Rowan University School of Osteopathic Medicine
Career Start Year 1985
Number of shared co-authors 0
Argonne National Laboratory
Career Start Year 1985
Number of shared co-authors 0
National Institute of Advanced Industrial Science and Technology (AIST)
Career Start Year 1985
Number of shared co-authors 0
Nara Institute of Science and Technology
Career Start Year 1984
Number of shared co-authors 0
Texas A&M University and Texas Agrilife Research, College Station
Career Start Year 1983
Number of shared co-authors 0
Midwest Center for Structural Genomics, Argonne National Laboratory
Career Start Year 1982
Number of shared co-authors 0
Yale-NUS College Singapore
Career Start Year 1981
Number of shared co-authors 0
Texas A&M University, College Station
Career Start Year 1979
Number of shared co-authors 0
The Genome Center at Washington University, Washington University School of Medicine
Career Start Year 1979
Number of shared co-authors 0
University of Calgary
Career Start Year 1979
Number of shared co-authors 0
Shinshu University School of Medicine
Career Start Year 1979
Number of shared co-authors 0
Indiana University Bloomington
Career Start Year 1978
Number of shared co-authors 0
Virginia Commonwealth University.
Career Start Year 1978
Number of shared co-authors 0
Midwest Center for Structural Genomics, Argonne National Laboratory
Career Start Year 1975
Number of shared co-authors 0
Institute of Molecular Biology "Roumen Tsanev",Bulgarian Academy of Sciences
Career Start Year 1974
Number of shared co-authors 0
Stanley Institute for Cognitive Genomics
Career Start Year 1974
Number of shared co-authors 0
Stanford University
Career Start Year 1974
Number of shared co-authors 3
The Genome Institute at Washington University
Career Start Year 1972
Number of shared co-authors 0
University of Hong Kong
Career Start Year 1969
Number of shared co-authors 0
University of California san francisco
Career Start Year 1968
Number of shared co-authors 0
Stanford University
Career Start Year 1968
Number of shared co-authors 1
Calico Life Sciences LLC
Career Start Year 1968
Number of shared co-authors 1
Robert Wood Johnson Medical School, Rutgers University
Career Start Year 1961
Number of shared co-authors 0
Monterotondo Mouse Clinic (MMC), Italian National Research Council (CNR)
Career Start Year 1961
Number of shared co-authors 0
NIH/National Institute of Ageing
Career Start Year 1960
Number of shared co-authors 5

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 6
University of Maryland School of Medicine
Co-authored papers 4
University of Maryland School of Medicine
Co-authored papers 4
University of Maryland School of Medicine
Co-authored papers 3
University of Maryland School of Medicine
Co-authored papers 3
University of Maryland School of Medicine
Co-authored papers 3
University of Maryland School of Medicine
Co-authored papers 3
University of Maryland
Co-authored papers 2
Co-authored papers 2
Veterans Administration Medical Center
Co-authored papers 2
University of Maryland
Co-authored papers 2
University of Maryland School of Medicine
Co-authored papers 2
University of Maryland Medical Center
Co-authored papers 2
University of Maryland
Co-authored papers 2
Greenebaum Comprehensive Cancer Center, University of Maryland
Co-authored papers 2
University of Maryland
Co-authored papers 2
Howard University Hospital
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Stanford University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Vanderbilt University Medical Center.
Co-authored papers 1
Oak Ridge National Laboratory
Co-authored papers 1
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 1
Geisinger Medical Center
Co-authored papers 1
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Mayo Clinic
Co-authored papers 1